Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Showing results for milena cruzi a da silva
Your search for Mylena Cruzinha da Silva retrieved no results
Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy.
Vasconcelos JF, Meira CS, Silva DN, Nonaka CKV, Daltro PS, Macambira SG, Domizi PD, Borges VM, Ribeiro-Dos-Santos R, de Freitas Souza BS, Soares MBP. Vasconcelos JF, et al. Sci Rep. 2017 Jul 21;7(1):6171. doi: 10.1038/s41598-017-06275-z. Sci Rep. 2017. PMID: 28733584 Free PMC article.
Here we evaluated the therapeutic potential of N,N-dimethylsphingosine(DMS), which blocks the production of sphingosine-1-phosphate(S1P), a mediator of cellular events during inflammatory responses, in a model of chronic Chagas disease cardiomyopathy. DMS-treated, Trypanosoma …
Here we evaluated the therapeutic potential of N,N-dimethylsphingosine(DMS), which blocks the production of sphingosine-1-phosphate(S1P), a …
Immunological profile of acute Chagas disease patients infected via oral transmission and treated with Benznidazole: a two-year follow-up of immune responses.
Firmino LF, Vaitkevicius-Antão V, Nascimento AV, Costa-Oliveira CN, Barros MDS, Torres DJL, Silva-Junior CD, Torreão BC, Silva MBA, Medeiros CA, Silva TFLD, Albuquerque MAB, Silva MMM, Batista FP, Montenegro D, Oliveira-Júnior W, Carrazzone C, Martins SM, Soares AKA, Lorena VMB. Firmino LF, et al. Immunobiology. 2026 Mar;231(2):153169. doi: 10.1016/j.imbio.2026.153169. Epub 2026 Feb 18. Immunobiology. 2026. PMID: 41740468 Free article.